Literature DB >> 21611815

Critical appraisal of the International Study Group of Pancreatic Surgery (ISGPS) consensus definition of postoperative hemorrhage after pancreatoduodenectomy.

Thilo Welsch1, Hanna Eisele, Stefanie Zschäbitz, Ulf Hinz, Markus W Büchler, Moritz N Wente.   

Abstract

PURPOSE: Postpancreatectomy hemorrhage (PPH) is one of the most serious complications after pancreatoduodenectomy (PD). This study analyzed and validated the International Study Group of Pancreatic Surgery (ISGPS) definition of PPH and aimed to identify risk factors for early (<24 h) and late PPH.
METHODS: Patients who underwent PD for pancreatic head tumors between 2001 and 2008 were included and complications were prospectively recorded. Factors associated with PPH were assessed by uni- and multivariate analysis.
RESULTS: Complete datasets were available for 796 patients. Classic and pylorus-preserving PD was performed in 13.8% and 86.2% of the patients, respectively. According to the ISGPS definition, PPH occurred in 29.1% of the cases (232 of 796 patients): 4.8% grade A, 15.2% grade B, and 9.2% grade C. The definition is based largely on surrogate markers (e.g., transfusion requirement) that are affected by other critical illnesses and more than 97% of patients with mild PPH had no clinical signs of bleeding. The need for postoperative intensive care as well as the incidence of pancreatic fistula, relaparotomy, and mortality rates significantly increased from grades A to C. Thirty-seven patients (4.6%) required interventional (endoscopy or angiography) and/or relaparotomy for PPH. Relaparotomy for PPH was performed in 3.1% of all patients. Independent risk factors for early PPH were preoperative anemia (hemoglobin, <11 mg/dl) and multivisceral resection while advanced age, chronic renal insufficiency, increased blood loss, and long operation time were associated with late PPH.
CONCLUSIONS: The ISGPS definition of PPH is feasible and applicable but produces a high rate of false positive mild PPH cases. The different grades still significantly correlate with relevant outcome variables, thus the definition discriminates postoperative courses, but a minor modification of the definition of mild PPH is suggested. The new results further demonstrate the need to optimize preoperative anemia and chronic renal insufficiency.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21611815     DOI: 10.1007/s00423-011-0811-x

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  30 in total

Review 1.  Risk-benefit assessment of closed intra-abdominal drains after pancreatic surgery: a systematic review and meta-analysis assessing the current state of evidence.

Authors:  Markus K Diener; Keyvan Tadjalli-Mehr; Keyvan-Tadjalli Mehr; Moritz N Wente; Meinhard Kieser; Markus W Büchler; Christoph M Seiler
Journal:  Langenbecks Arch Surg       Date:  2010-10-21       Impact factor: 3.445

2.  1423 pancreaticoduodenectomies for pancreatic cancer: A single-institution experience.

Authors:  Jordan M Winter; John L Cameron; Kurtis A Campbell; Meghan A Arnold; David C Chang; Joann Coleman; Mary B Hodgin; Patricia K Sauter; Ralph H Hruban; Taylor S Riall; Richard D Schulick; Michael A Choti; Keith D Lillemoe; Charles J Yeo
Journal:  J Gastrointest Surg       Date:  2006-11       Impact factor: 3.452

3.  Intraoperative transfusion: is it a real prognostic factor of periampullary cancer following pancreatoduodenectomy?

Authors:  Sang-Jae Park; Sun-Whe Kim; Jin-Young Jang; Kuhn-Uk Lee; Yong-Hyun Park
Journal:  World J Surg       Date:  2002-02-04       Impact factor: 3.352

4.  Ten-year experience with 733 pancreatic resections: changing indications, older patients, and decreasing length of hospitalization.

Authors:  J H Balcom; D W Rattner; A L Warshaw; Y Chang; C Fernandez-del Castillo
Journal:  Arch Surg       Date:  2001-04

5.  Pancreaticoduodenectomy can be performed safely in patients aged 80 years and older.

Authors:  Minna K Lee; Joseph Dinorcia; Patrick L Reavey; Marc M Holden; Jeanine M Genkinger; James A Lee; Beth A Schrope; John A Chabot; John D Allendorf
Journal:  J Gastrointest Surg       Date:  2010-09-08       Impact factor: 3.452

6.  Pancreatoduodenectomy for ductal adenocarcinoma in the very elderly; is it safe and justified?

Authors:  Saboor Khan; Guido Sclabas; Kaye Reid Lombardo; Michael G Sarr; David Nagorney; Michael L Kendrick; John H Donohue; Florencia G Que; Michael B Farnell
Journal:  J Gastrointest Surg       Date:  2010-08-17       Impact factor: 3.452

7.  Risk factors for complications after pancreatic head resection.

Authors:  Ulrich Adam; Frank Makowiec; Hartwig Riediger; Wolfgang D Schareck; Stefan Benz; Ulrich T Hopt
Journal:  Am J Surg       Date:  2004-02       Impact factor: 2.565

8.  Results of non-operative therapy for delayed hemorrhage after pancreaticoduodenectomy.

Authors:  Laura Beyer; Rémi Bonmardion; Sandrine Marciano; Olivier Hartung; Olivier Ramis; Lénaïk Chabert; Marc Léone; Olivier Emungania; Pierre Orsoni; Marc Barthet; Stéphane V Berdah; Christian Brunet; Vincent Moutardier
Journal:  J Gastrointest Surg       Date:  2009-02-18       Impact factor: 3.452

9.  Postpancreatectomy hemorrhage: diagnosis and treatment: an analysis in 1669 consecutive pancreatic resections.

Authors:  Emre F Yekebas; Lars Wolfram; Guellue Cataldegirmen; Christian R Habermann; Dean Bogoevski; Alexandra M Koenig; Jussuf Kaifi; Paulus G Schurr; Michael Bubenheim; Claus Nolte-Ernsting; Gerhard Adam; Jakob R Izbicki
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

10.  Delayed massive haemorrhage after pancreatic and biliary surgery.

Authors:  M I van Berge Henegouwen; J H Allema; T M van Gulik; P C Verbeek; H Obertop; D J Gouma
Journal:  Br J Surg       Date:  1995-11       Impact factor: 6.939

View more
  21 in total

1.  Postpancreatectomy hemorrhage (PPH): predictors and management from a prospective database.

Authors:  B Darnis; R Lebeau; X Chopin-Laly; M Adham
Journal:  Langenbecks Arch Surg       Date:  2013-02-26       Impact factor: 3.445

Review 2.  Delayed Gastric Emptying After Pancreaticoduodenectomy: Is Subtotal Stomach Preserving Better or Pylorus Preserving?

Authors:  Mena M Hanna; Mena Hanna; Rahul Gadde; Leonardo Tamariz; Casey J Allen; Casey Allen; Jonathan P Meizoso; Jonathan Meizoso; Danny Sleeman; Alan S Livingstone; Alan Livingstone; Danny Yakoub
Journal:  J Gastrointest Surg       Date:  2015-04-11       Impact factor: 3.452

3.  Clinical impact of preoperative acute pancreatitis in patients who undergo pancreaticoduodenectomy for periampullary tumors.

Authors:  Yong-Hua Chen; Si-Ming Xie; Hao Zhang; Chun-Lu Tan; Neng-Wen Ke; Gang Mai; Xu-Bao Liu
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

4.  Superior mesenteric artery first combined with uncinate process approach versus uncinate process first approach in pancreatoduodenectomy: a comparative study evaluating perioperative outcomes.

Authors:  Shailesh V Shrikhande; Savio George Barreto; Yashodhan D Bodhankar; Kunal Suradkar; Guruprasad Shetty; Rohini Hawaldar; Mahesh Goel; Parul J Shukla
Journal:  Langenbecks Arch Surg       Date:  2011-07-08       Impact factor: 3.445

5.  Is preoperative withdrawal of aspirin necessary in patients undergoing elective inguinal hernia repair?

Authors:  Wilson Ong; Tong Shen; Wee Boon Tan; Davide Lomanto
Journal:  Surg Endosc       Date:  2016-04-29       Impact factor: 4.584

6.  A randomised controlled pilot trial to evaluate and optimize the use of anti-platelet agents in the perioperative management in patients undergoing general and abdominal surgery--the APAP trial (ISRCTN45810007).

Authors:  D Antolovic; A Rakow; P Contin; A Ulrich; N N Rahbari; M W Büchler; J Weitz; M Koch
Journal:  Langenbecks Arch Surg       Date:  2011-11-03       Impact factor: 3.445

7.  Hemorrhage after pancreaticoduodenectomy: does timing matter?

Authors:  Gyulnara G Kasumova; Mariam F Eskander; Tara S Kent; Sing Chau Ng; A James Moser; Muneeb Ahmed; Douglas K Pleskow; Mark P Callery; Jennifer F Tseng
Journal:  HPB (Oxford)       Date:  2016-08-11       Impact factor: 3.647

Review 8.  Development of a composite endpoint for randomized controlled trials in pancreaticoduodenectomy.

Authors:  Marielle M E Coolsen; Stefan H E M Clermonts; Ronald M van Dam; Bjorn Winkens; Massimo Malagó; Giuseppe K Fusai; Cornelis H C Dejong; Steven W M Olde Damink
Journal:  World J Surg       Date:  2014-06       Impact factor: 3.352

9.  Implementing an enhanced recovery program after pancreaticoduodenectomy in elderly patients: is it feasible?

Authors:  Mariëlle M E Coolsen; Maikel Bakens; Ronald M van Dam; Steven W M Olde Damink; Cornelis H C Dejong
Journal:  World J Surg       Date:  2015-01       Impact factor: 3.352

10.  Early biliary complications following pancreaticoduodenectomy: prevalence and risk factors.

Authors:  Brice Malgras; Sandrine Duron; Sébastien Gaujoux; Safi Dokmak; Béatrice Aussilhou; Vinciane Rebours; Maxime Palazzo; Jacques Belghiti; Alain Sauvanet
Journal:  HPB (Oxford)       Date:  2016-01-29       Impact factor: 3.647

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.